It has been shown that PPARγ agonists appear to have direct neuroprotective actions in several different animal models, like Alzheimer’s disease (AD), stroke, multiple sclerosis (MS), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (Sundararajan et al., 2006). Here, PPARG is linked to Alzheimer disease.